INM — INMED PHARMACEUTICALS INC
As of Q2 2026, 1 SEC-registered investment managers reported holding INM (INMED PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $40.43K across 26.08K shares. That is -52.6% by share count (-28.96K shares) versus the previous quarter, while reported value moved +13.9%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
INM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BNY Mellon history | Q4 2022 | 300.00K | $291.55K | 0.00% | New |
| Millennium Management history | Q3 2022 | 13.92K | $91.00K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 26.08K | $40.43K | 0.00% | Reduce |
| Renaissance Technologies history | Q3 2025 | 16.80K | $36.79K | 0.00% | New |
| UBS Group AG history | Q1 2026 | 8.07K | $5.20K | 0.00% | Add |
| Bank of America Corp history | Q3 2024 | 100 | $24 | 0.00% | Hold |
| Morgan Stanley history | Q4 2022 | 1 | $2 | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- UBS Group AG sold 8.07K sh · $5.20K
Fund Position History — shares by quarter (top 7 funds)
| Fund | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | — | — | — | — | — | 34.01K | 12.72K | 12.10K | 56.67K | — | — | — | — | — | 46.97K | 26.08K |
| Renaissance Technologies | — | — | 77.50K | — | — | 38.90K | 28.30K | — | 50.30K | — | — | — | 16.80K | — | — | — |
| UBS Group AG | 5.80K | 831 | 2.62K | — | 69 | — | 41 | — | 212.04K | 10.41K | 6.11K | 7.76K | — | 377 | 8.07K | — |
| Morgan Stanley | 134 | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | 6.77K | — | 1.82K | 1.83K | — | 100 | 100 | 100 | 100 | — | — | — | — | — | — | — |
| BNY Mellon | — | 300.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | 13.92K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details